Industry
If you would like to subscribe to Middle East & Africa Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Middle East & Africa Pharma & Healthcare Insight please click on the trial link below.
Meningitis Vaccination Advances
March 2008 | Industry NewsSorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Middle East & Africa Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Middle East & Africa Pharma & Healthcare Insight please click on the trial link below.
There has been significant progress on a low cost vaccination against Neisseria meningitidis, one of two strains of bacteria that cause the majority of Africa's meningitis caseload. Phase III clinical trials conducted in the Gambia, Senegal and Mali have shown positive results, and it is expected that the vaccine can be introduced from